Výsledky vyhledávání - "Jörg Splittgerber"

Abstract LB-316: Pharmacological and immunological characterization of the therapeutic anti-EGFR antibodies cetuximab, panitumumab and matuzumab: The combination of cetuximab and matuzumab results in enhanced effector functions

Autor: Andree Blaukat, Jürgen Schmidt, Jörg Splittgerber, Christof Reusch, Christopher Stroh

Publikováno v: Cancer Research. 70:LB-316

Background: Therapeutic antibodies can attack tumor cells by functionally interfering with the target and/or by employing immune effector mechanisms such as antibody-dependent cellular cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1527b7f9594c8bed50c85b8c6a1134a
https://doi.org/10.1158/1538-7445.am10-lb-316

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání